Alejandra Gomez‐Cadena

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Sara Trabanelli, Mathieu F. Chevalier, Amaia Martínez-Usatorre et al. · Nature Communications · 2017 · 226 citations · Full text

Life Sciences, Immunology, Oncology +16

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions

Giuseppe Ercolano, Alejandra Gomez‐Cadena, Nina Dumauthioz et al. · Nature Communications · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model

Claudia Urueña, Juan Mancipe, John Fredy Hernández et al. · BMC Complementary and Alternative Medicine · 2013 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model

Alejandra Gomez‐Cadena, Claudia Urueña, Karol Prieto et al. · Cell Death and Disease · 2016 · 64 citations · Full text

Life Sciences, Immunology, Oncology +17

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

Bérengère Salomé, Alejandra Gomez‐Cadena, Romain Loyon et al. · Blood Advances · 2019 · 64 citations · Full text

Life Sciences, Hematology, Immunology +7